Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The drug can quickly reverse opioid-driven overdoses.
An analysis of 15,000 insured people with HIV also confirmed past findings that single-tablet regimens are associated with higher adherence.
Researchers analyzed data from 42 HIV centers in 11 Latin American nations.
ViiV Healthcare and GlaxoSmithKline are jointly developing GSK3640254.
The longer people in a British study had been living with diagnosed HIV, the more likely they were to have depression and anxiety.
Among a group of largely HIV-positive gay and bi men, Zepatier (grazoprevir/elbasvir) boasted a 99 percent cure rate.
Certain subgroups of this population, such as smokers and those with depression, are less likely to have an undetectable viral load.
A recent small study compared objective and subjective fatigue among those with and without HIV who were age 50 and older.
This finding falls in line with numerous analyses that show that PrEP’s benefits are largely not reaching Black gay and bi men.
In a 111-person group of people treated for HIV, the average viral reservoir half-life was 12 years.
Harvoni (ledipasvir/sofosbuvir) is proving highly successful at treating hepatitis C among people coinfected with HIV and genotype 1 of hep C...
Advocates argue that the proposed criteria are dangerous for people living with the deadly liver disease.
People who want to opt out of the settlement have until June 23.
Truvada as pre-exposure prophylaxis (PrEP) against HIV takes an estimated week to reach full efficacy and may protect for nearly a week...
The Sovaldi/ledipasvir combination pill to treat hepatitis C does not have a clinically significant impact on five common HIV antiretrovirals.
Very early treatment can help suppress the development of the viral reservoir in monkeys infected with SIV, HIV’s simian cousin.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.